License
Copyright (c) 2022 Mireya Carballeda Camacho, Francisco Javier Ruiz del Olmo
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The author(s) declare(s) that (download model):
1.- This proposal includes original and innovative contributions. The author(s) certify that this work has not been published completely or partially through any other means or is under consideration by any other journal.
2.- The author(s) accept the guidelines for writing, publication, review and evaluation established by Fonseca, Journal of Communication.
3.- The author(s) are responsible of the contents of the submitted article and declare that they have contributed to the conception, design and creation of this work, the analysis and interpretation of data, and the writing of the text and its possible reviewed version, as well as to the approval of the final submitted version.
4.-. The author(s) have been informed that there may be changes in the style of the manuscript. However, the author(s) will be sent the final galley proofs before the text (in case of a positive review) is finally published as an article. The author(s) will give tacit approval to the galley proofs if they do not submit a response within 10 working days after receiving them.
5.- The author(s) are aware that publishing an article in Fonseca, Journal of Communication is not remunerated and does not entail any associated cost.
6.- The author(s) declare(s) not to be by any personal or commercial links that could represent a conflict of interest in connection with the article submitted, and that he/she/they has/have respected the ethical principles of research.
7.- The undersigned author(s) transfer(s) the copyright of this manuscript to Fonseca, Journal of Communication to be published under a Creative Commons License (with the rights described at the bottom of the main page of Fonseca, Journal of Communication: http://fjc.usal.es). The author(s) cede the rights to edition and reproduction of the manuscript.